Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5–6 years

Update your browser to view ScienceDirect.

Request details:

Request ID: 8ebda4e71d3467ad-LAX
IP: 47.97.18.252
UTC time: 2024-12-02T19:15:10+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4